# Effect of Albumin Administration in Hypoalbuminemic Hospitalized Patients With Community-acquired Pneumonia.

> **NCT04071041** · PHASE3 · TERMINATED · sponsor: **Jordi Carratala** · enrollment: 39 (actual)

## Conditions studied

- Community-acquired Pneumonia
- Hypoalbuminemia

## Interventions

- **DRUG:** Albumin Human

## Key facts

- **NCT ID:** NCT04071041
- **Lead sponsor:** Jordi Carratala
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-10-31
- **Primary completion:** 2021-10-31
- **Final completion:** 2021-10-31
- **Target enrollment:** 39 (ACTUAL)
- **Why stopped:** Low recruitment
- **Last updated:** 2023-01-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04071041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04071041, "Effect of Albumin Administration in Hypoalbuminemic Hospitalized Patients With Community-acquired Pneumonia.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04071041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*